Literature DB >> 2992263

Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease.

J T Salonen, R Salonen, I Penttilä, J Herranen, M Jauhiainen, M Kantola, R Lappeteläinen, P H Mäenpää, G Alfthan, P Puska.   

Abstract

The independent association of serum concentrations of saturated and polyunsaturated fatty acids, apolipoproteins AI and B, selenium and vitamins A and E with the risk of death from coronary artery disease (CAD) was studied in 92 persons with no previous myocardial infarction, who died from CAD during a 5-year follow-up, and their 92 1-to-1 matched controls. Case-control pairs came from a randomly drawn population sample of approximately 12,000 persons aged 30 to 64 years from 2 provinces of eastern Finland, an area with exceptionally high CAD mortality. Control subjects were matched for sex, age, serum cholesterol, mean arterial pressure, tobacco consumption and history of cardiovascular diseases. The persons who died of CAD had lower serum esterified arachidonic acid concentrations before follow-up than the control subjects (41 vs 48 mg/liter, p = 0.05), and this difference was greater for pairs with no chest pain on effort (36 vs 50 mg/liter, p less than 0.05). The adjusted risk of CAD death in persons with a serum polyunsaturated to saturated (P/S) fatty acid ratio of 0.28 or less (in the lowest tertile) was 3.5-fold (95% confidence interval [CI], 1.5 to 8.2) compared with those with higher serum P/s ratios in a multivariate logistic model and 5.6-fold (95% CI 1.6 to 19.8) for pairs with no chest pain on effort. A low serum apolipoprotein AI concentration (1.25 g/liter or less, in the lowest tertile) was associated with a 2.5-fold (95% CI 1.1 to 5.7) adjusted risk of CAD death among the chest pain-free persons.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992263     DOI: 10.1016/0002-9149(85)90839-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Beta-carotene intake and risk of nonfatal acute myocardial infarction in women.

Authors:  A Tavani; E Negri; B D'Avanzo; C La Vecchia
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

2.  [Vitamin E distribution of lipoproteins in patients with coronary heart disease].

Authors:  T Purcz; W Reuter; B Vorberg; I Sauer; A Neugebauer
Journal:  Z Ernahrungswiss       Date:  1996-09

3.  Selenium status and cardiovascular diseases: meta-analysis of prospective observational studies and randomized controlled trials.

Authors:  X Zhang; C Liu; J Guo; Y Song
Journal:  Eur J Clin Nutr       Date:  2015-05-20       Impact factor: 4.016

4.  Selenium and coronary heart disease: a meta-analysis.

Authors:  Gemma Flores-Mateo; Ana Navas-Acien; Roberto Pastor-Barriuso; Eliseo Guallar
Journal:  Am J Clin Nutr       Date:  2006-10       Impact factor: 7.045

Review 5.  Dietary antioxidants, cancer, and atherosclerotic heart disease.

Authors:  D L Tribble; E Frank
Journal:  West J Med       Date:  1994-12

Review 6.  Physiological and nutritional importance of selenium.

Authors:  J Nève
Journal:  Experientia       Date:  1991-02-15

7.  Clinical and therapeutic use of probucol.

Authors:  A Berg; M W Baumstark; I Frey; M Halle; J Keul
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Regulation of expression of apolipoprotein A-I by selenium status in human liver hepatoblastoma cells.

Authors:  Jessica A Stahle; Hema Vunta; C Channa Reddy; K Sandeep Prabhu
Journal:  Eur J Nutr       Date:  2009-03-18       Impact factor: 5.614

Review 9.  Selenium levels and hypertension: a systematic review of the literature.

Authors:  Dulanji Kuruppu; Hugh C Hendrie; Lili Yang; Sujuan Gao
Journal:  Public Health Nutr       Date:  2013-04-16       Impact factor: 4.022

10.  Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey, 2003-2004.

Authors:  Joachim Bleys; Ana Navas-Acien; Martin Laclaustra; Roberto Pastor-Barriuso; Andy Menke; Jose Ordovas; Saverio Stranges; Eliseo Guallar
Journal:  Am J Epidemiol       Date:  2009-02-16       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.